Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Head Neck ; 38(2): 237-46, 2016 Feb.
Article in English | MEDLINE | ID: mdl-25244076

ABSTRACT

BACKGROUND: Oncolytic viral efficacy may be limited by the penetration of the virus into tumors. This may be enhanced by intraoperative application of virus immediately after surgical resection. METHODS: Oncolytic vaccinia virus GLV-1h68 was delivered in silk-elastin-like protein polymer (SELP) in vitro and in vivo in anaplastic thyroid carcinoma cell line 8505c in nude mice. RESULTS: GLV-1h68 in SELP infected and lysed anaplastic thyroid cancer cells in vitro equally as effectively as in phosphate-buffered saline (PBS), and at 1 week retains a thousand fold greater infectious plaque-forming units. In surgical resection models of residual tumor, GLV-1h68 in SELP improves tumor control and shows increased viral ß-galactosidase expression as compared to PBS. CONCLUSION: The use of SELP matrix for intraoperative oncolytic viral delivery protects infectious viral particles from degradation, facilitates sustained viral delivery and transgene expression, and improves tumor control. Such optimization of methods of oncolytic viral delivery may enhance therapeutic outcomes.


Subject(s)
Oncolytic Virotherapy/methods , Oncolytic Viruses , Thyroid Neoplasms/immunology , Vaccinia virus , Animals , Biopolymers , Cell Line, Tumor , Fibroins , Fibronectins , Intraoperative Care , Mice, Nude , Recombinant Fusion Proteins , Thyroid Neoplasms/surgery , Viral Plaque Assay , Xenograft Model Antitumor Assays , beta-Galactosidase/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL